Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast CancerN. Engl. J. Med 2022 Jun 05;[EPub Ahead of Print], S Modi, W Jacot, T Yamashita, J Sohn, M Vidal, E Tokunaga, J Tsurutani, NT Ueno, A Prat, YS Chae, KS Lee, N Niikura, YH Park, B Xu, X Wang, M Gil-Gil, W Li, JY Pierga, SA Im, HCF Moore, HS Rugo, R Yerushalmi, F Zagouri, A Gombos, SB Kim, Q Liu, T Luo, C Saura, P Schmid, T Sun, D Gambhire, L Yung, Y Wang, J Singh, P Vitazka, G Meinhardt, N Harbeck, DA Cameron
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.